Melanie Hamann

1.0k total citations
48 papers, 799 citations indexed

About

Melanie Hamann is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Melanie Hamann has authored 48 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cellular and Molecular Neuroscience, 32 papers in Neurology and 7 papers in Molecular Biology. Recurrent topics in Melanie Hamann's work include Neurological disorders and treatments (31 papers), Neuroscience and Neuropharmacology Research (21 papers) and Genetic Neurodegenerative Diseases (17 papers). Melanie Hamann is often cited by papers focused on Neurological disorders and treatments (31 papers), Neuroscience and Neuropharmacology Research (21 papers) and Genetic Neurodegenerative Diseases (17 papers). Melanie Hamann collaborates with scholars based in Germany, United States and Canada. Melanie Hamann's co-authors include Angelika Richter, Franziska Richter, Mustapha Bennay, Manuela Gernert, Wolfgang Löscher, A. Richter, Rüdiger Köhling, Miriam H. Meisler, Wassilios G. Meissner and José N. Nóbrega and has published in prestigious journals such as Journal of Neuroscience, Scientific Reports and Brain Research.

In The Last Decade

Melanie Hamann

47 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melanie Hamann Germany 17 504 466 140 77 68 48 799
Caroline Chevarin France 16 421 0.8× 192 0.4× 315 2.3× 64 0.8× 58 0.9× 30 898
Milica Cerovic Italy 16 468 0.9× 264 0.6× 362 2.6× 194 2.5× 87 1.3× 23 973
Meleik A. Hebert United States 12 549 1.1× 182 0.4× 301 2.1× 163 2.1× 107 1.6× 12 980
Kimberly A. Leite‐Morris United States 20 508 1.0× 91 0.2× 278 2.0× 44 0.6× 161 2.4× 27 888
Linda I. Anderson United States 13 357 0.7× 113 0.2× 118 0.8× 24 0.3× 62 0.9× 14 526
David L. Felten United States 9 346 0.7× 110 0.2× 177 1.3× 120 1.6× 27 0.4× 11 712
Beom S. Jeon South Korea 17 575 1.1× 567 1.2× 340 2.4× 177 2.3× 30 0.4× 38 1.0k
Dave Gagnon Canada 12 346 0.7× 218 0.5× 131 0.9× 50 0.6× 93 1.4× 16 536
Nina Pan United States 6 221 0.4× 145 0.3× 282 2.0× 39 0.5× 89 1.3× 8 705
Ori J. Lieberman United States 11 197 0.4× 160 0.3× 196 1.4× 54 0.7× 76 1.1× 22 561

Countries citing papers authored by Melanie Hamann

Since Specialization
Citations

This map shows the geographic impact of Melanie Hamann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Hamann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Hamann more than expected).

Fields of papers citing papers by Melanie Hamann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Hamann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Hamann. The network helps show where Melanie Hamann may publish in the future.

Co-authorship network of co-authors of Melanie Hamann

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Hamann. A scholar is included among the top collaborators of Melanie Hamann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Hamann. Melanie Hamann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hein, Arne, et al.. (2024). Pharmaceutical consumption in human and veterinary medicine in Germany: potential environmental challenges. Frontiers in Environmental Science. 12. 2 indexed citations
2.
3.
Hamann, Melanie, et al.. (2019). Adverse Drug Reactions After Administration of Emodepside/Praziquantel (Profender®) in an MDR1-Mutant Australian Shepherd Dog: Case Report. Frontiers in Veterinary Science. 6. 296–296. 12 indexed citations
4.
Rummel, Christoph, et al.. (2019). Suspected neurological toxicity after oral application of fluralaner (Bravecto®) in a Kooikerhondje dog. BMC Veterinary Research. 15(1). 283–283. 14 indexed citations
5.
Richter, Angelika, Melanie Hamann, Jörg Wissel, & Holger A. Volk. (2015). Dystonia and Paroxysmal Dyskinesias: Under-Recognized Movement Disorders in Domestic Animals? A Comparison with Human Dystonia/Paroxysmal Dyskinesias. Frontiers in Veterinary Science. 2. 65–65. 22 indexed citations
6.
Scherr, Martin, Melanie Hamann, Dirk Schwerthöffer, et al.. (2011). Environmental risk factors and their impact on the age of onset of schizophrenia: Comparing familial to non-familial schizophrenia. Nordic Journal of Psychiatry. 66(2). 107–114. 22 indexed citations
7.
Lange, Naomi F., et al.. (2011). Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned rats. Neuropharmacology. 62(2). 1052–1061. 22 indexed citations
8.
Leblois, Arthur, René Reese, Melanie Hamann, et al.. (2010). Deep brain stimulation changes basal ganglia output nuclei firing pattern in the dystonic hamster. Neurobiology of Disease. 38(2). 288–298. 23 indexed citations
9.
Hamann, Melanie. (2010). Non-invasive genotyping of transgenic mice: comparison of different commercial kits and required amounts. ALTEX. 27(3). 185–190. 8 indexed citations
10.
Hamann, Melanie, et al.. (2010). Behavioural and pharmacological examinations in a transgenic mouse model of early-onset torsion dystonia. Pharmacology Biochemistry and Behavior. 97(4). 647–655. 12 indexed citations
11.
Hamann, Melanie, et al.. (2008). Extracellular amino acid levels in the striatum of the dtsz mutant, a model of paroxysmal dystonia. Neuroscience. 157(1). 188–195. 3 indexed citations
12.
Hamann, Melanie, Angelika Richter, Heidrun Fink, & André Rex. (2008). Altered nicotinamide adenine dinucleotide (NADH) fluorescence in dtsz mutant hamsters reflects differences in striatal metabolism between severe and mild dystonia. Journal of Neuroscience Research. 87(3). 776–783. 9 indexed citations
13.
14.
Hamann, Melanie, et al.. (2005). Age-Dependent Alterations of Striatal Calretinin Interneuron Density in a Genetic Animal Model of Primary Paroxysmal Dystonia. Journal of Neuropathology & Experimental Neurology. 64(9). 776–781. 27 indexed citations
15.
Harnack, Daniel, Melanie Hamann, Wassilios G. Meissner, et al.. (2004). High-frequency stimulation of the entopeduncular nucleus improves dystonia in dtsz hamsters. Neuroreport. 15(9). 1391–1393. 17 indexed citations
16.
Hamann, Melanie & Angelika Richter. (2004). Effects of rubral microinjections of muscimol and bicuculline in a genetic animal model of paroxysmal dystonia. Brain Research. 1008(1). 126–130. 2 indexed citations
17.
Richter, Angelika & Melanie Hamann. (2004). The carbonic anhydrase inhibitor acetazolamide exerts antidystonic effects in the dtsz mutant hamster. European Journal of Pharmacology. 502(1-2). 105–108. 6 indexed citations
18.
Hamann, Melanie & Angelika Richter. (2002). Effects of striatal injections of GABAA receptor agonists and antagonists in a genetic animal model of paroxysmal dystonia. European Journal of Pharmacology. 443(1-3). 59–70. 29 indexed citations
19.
Nóbrega, José N., et al.. (2002). Changes in AMPA Receptor Binding in an Animal Model of Inborn Paroxysmal Dystonia. Experimental Neurology. 176(2). 371–376. 15 indexed citations
20.
Tulusan, A. H., et al.. (1982). Correlations of the receptor content and ultrastructure of breast cancer cells. Archives of Gynecology and Obstetrics. 231(3). 177–184. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Chevarin Breakdown of academic impact, for papers by Milica Cerovic Breakdown of academic impact, for papers by Meleik A. Hebert Breakdown of academic impact, for papers by Kimberly A. Leite‐Morris Breakdown of academic impact, for papers by Linda I. Anderson Breakdown of academic impact, for papers by David L. Felten Breakdown of academic impact, for papers by Beom S. Jeon Breakdown of academic impact, for papers by Dave Gagnon Breakdown of academic impact, for papers by Nina Pan Breakdown of academic impact, for papers by Ori J. Lieberman
Rankless by CCL
2026